First Drug Approved for Ultra-Rare Kidney Disease
MedPage Today,
Nephrology > General Nephrology Complement 3 glomerulopathy approval marks the third indication for iptacopan by Kristen Monaco…
WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
Overview of attention for article published in Kidney International Reports, February 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (80th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (58th percentile)
Readers on
- mendeley
- 13 Mendeley